Richard Master, CEO of MCS Industries, mobilized a team of documentary filmmakers and researchers to connect the dots surrounding high U.S. medication prices, twice as high as costs in other countries. With no regulation, U.S. Pharma costs are out of control, contributing to escalating costs of health coverage. Even as U.S. taxpayers fund 80 percent of biomedical research, a high percentage of "new" drugs promoted by pharma industry are "me too" drugs - existing drugs slightly tweaked.
 
    